Meeting
2020 ASCO Virtual Scientific Program
Comparison of StemPrintER, a novel biology-based genomic predictor of distant recurrence in breast cancer, with Oncotype DX in the TransATAC cohort.
Authors
Salvatore Pece
European Institute of Oncology, Milan, Italy
Salvatore Pece , Ivana Sestak , Francesca Montani , Micol Tillhon , Stefano Freddi , Patrick Maisonneuve , Marco Colleoni , Paolo Veronesi , Davide Disalvatore , Giuseppe Viale , Richard Buus , Jack M. Cuzick , Mitchell Dowsett , Pier Paolo Di Fiore
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Hormone Receptor-Positive
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1020)
DOI
10.1200/JCO.2020.38.15_suppl.1020
Abstract #
1020
Poster Bd #
105
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Integration of the stem cell biology-based genomic tool, StemPrintER, with clinicopathological parameters for the prediction of distant recurrence in ER+/HER2- breast cancer (BC) patients.
First Author: Salvatore Pece
Poster
2023 ASCO Breakthrough
Risk factors and predictors of tumor recurrence among breast cancer patients in a tertiary government hospital in the Philippines.
First Author: Omar Paningbatan Maaño
First Author: Oleg Gluz
Poster
2014 ASCO Annual Meeting
Comparison of the clinical treatment score with the adjuvant online score and the risk for recurrence score for estimating prognosis in early-stage high-risk breast cancer patients: A Hellenic Cooperative Oncology Group study.
First Author: Kyriaki Pliarchopoulou